Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Minocycline After Endovascular Thrombectomy for Acute Ischemic Stroke
NCT07594314Phase 3Recruiting
- Start
- May 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Minocycline group with placebo group (2 arms). Primary endpoint: Modified Rankin Scale score of 0-1 (Excellent outcome) at 90 days. Started May 2026; status: recruiting.
02
Drugs
minocycline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07594314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07594314.